Go back to Resources

Population Pharmacokinetics of Alfentanil in Children

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Go back to Resources

Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based Vaccines

Authors:

Volume:

Issue:

Journal:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Go back to Newsroom

New Mountain Capital Announces Growth Partnership with Emmes

Partnership to Support Emmes’ Next Phase of Tech-Enabled Growth

Download Go back to Newsroom

Go back to Newsroom

Emmes Introduces Telehealth Capabilities into Advantage eClinical

The latest upgrade is part of wider goals to create the industry’s first unified digital data platform for decentralized and hybrid trials
 

Download Go back to Newsroom

Go back to Newsroom

Emmes Appoints Peter Ronco as Chief Executive Officer

Ronco’s Global Pharmaceutical Experience Will Support the Next Chapter of Emmes’ Growth and Technology Enablement
 

Rockville, MD, September 20, 2023 – Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Peter Ronco has been named Chief Executive Officer, effective immediately.

Download Go back to Newsroom

Go back to Newsroom

Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies

Emmes collaborates with pharmaceutical companies as strategic partners, providing one-stop clinical trial services, reducing costs, and accelerating development.
 

Download Go back to Newsroom